Market Place
Sourcing Support
Radius Pharma Signs Agreement with Pharmanovia for Abaloparatide
02 Jan 2025 //
ACCESSWIRE
Lindis Licenses Catumaxomab to Pharmanovia for Commercialization
19 Nov 2024 //
ACCESSWIRE
Pharmanovia Acquires Rights To Treatment For Parkinson’s Disease
07 Oct 2024 //
BUSINESSWIRE
Pharmanovia Study Chloral Hydrate Improves Insomnia In 2 Weeks
01 Oct 2024 //
BUSINESSWIRE
Pharmanovia Appoints New General Manager for the DACH Region
06 Aug 2024 //
BUSINESSWIRE
Sanofi sells off clutch of CNS drugs to Pharmanovia
19 Sep 2023 //
FIERCE PHARMA
Pharmanovia Acquires Global Central Nervous System (CNS) Portfolio From Sanofi
18 Sep 2023 //
BUSINESSWIRE
Stealth BioTherapeutics Enters into Licensing Agreement with Pharmanovia
30 May 2023 //
PR NEWSWIRE
Closed Loop Medicine and Pharmanovia enter a co-development partnership
17 May 2023 //
BUSINESSWIRE
Pharmanovia and Closed Loop Medicine in precision medicine partnership
17 May 2023 //
PHARMATIMES
Pharmanovia Enters Into an Exclusive Licensing Agreement With Aeterna Zentaris
16 Mar 2023 //
BUSINESSWIRE
Pharmanovia to Market GHRYVELIN in the EEA and UK as Diagnostic Test for GHD
16 Mar 2023 //
GLOBENEWSWIRE
Axsome Enters into Agreement with Pharmanovia to Develop solriamfetol
22 Feb 2023 //
GLOBENEWSWIRE
Aquestive Therapeutics Enters License and Supply Agreement with Pharmanovia
28 Sep 2022 //
GLOBENEWSWIRE
DKSH and Pharmanovia partner to provide meds in Southeast Asia
07 Jul 2022 //
PHARMALETTER
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.